Heart 2009;95:1110-1111
Technology and guidelines
Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation: commentary
Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic, Cleveland, Ohio, USA
Dr A M Gillinov, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic/J4-1, 9500 Euclid Avenue, Cleveland, OH 44195, USA; gillinom@ccf.org
Accepted 30 March 2009
| The first 150 words of the full text of this article appear below. |
Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation (AF) is a new, minimally invasive surgical approach to treating AF. Because this procedure was developed only recently, there are few data documenting results of this new treatment. The National Institute for Health and Clinical Excellence has provided a guidance document concerning thoracoscopic epicardial radiofrequency ablation for AF. The key components of this document include (a) indications and current treatments; (b) an outline of the procedure; (c) reviews of efficacy and safety; (d) guidance about appropriate application of the procedure.
AF is the most common arrhythmia, affecting millions of people world wide. The combination of an ageing global population and the increased prevalence of AF in the elderly has set the stage for a dramatic increase in the number of people diagnosed with AF over the next two to three decades. While AF is well-tolerated
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
